Showing results (201-210 of 231) with videos related to
Sort By:
Pageof 24
Cancer Research|June 1, 2013
Radioresistant cancer cells can be conditioned to enter senescence by mTOR inhibitionHae Yun Nam, Myung Woul Han, Hyo Won Chang, et al.Cancer Letters|April 24, 2018
Novel cancer gene variants and gene fusions of triple-negative breast cancers (TNBCs) reveal their molecular diversity conserved in the patient-derived xenograft (PDX) modelJaeyun Jung, Kiwon Jang, Jung Min Ju, et al.Journal of Pathology and Translational Medicine|February 23, 2026
Prevalence of HER2-ultralow breast cancer in South Korea: a multicenter study by reassessment of HER2-zero casesMin Chong Kim, Eun Yoon Cho, Hee Jin Lee, et al.Cancer Research and Treatment|September 4, 2025
Long-Term Prognostic Value and Analytical Parameters of the Next-Generation Sequencing-Based Multigene Assay in Hormone Receptor-Positive, HER2-Negative Breast CancerHyunji Kim, Jiwon Koh, Hyunwoo Lee, et al.Theranostics|July 30, 2020
RNA-binding protein NONO contributes to cancer cell growth and confers drug resistance as a theranostic target in TNBCSeong-Jin Kim, Jin-Sung Ju, Myoung-Hee Kang, et al.Psychiatry Investigation|August 20, 2011
The changes of blood glucose control and lipid profiles after short-term smoking cessation in healthy malesSeong-Su Lee, Jeong-Seok Seo, Sung-Rae Kim, et al.Arthritis & Rheumatology (Hoboken, N.J.)|April 24, 2014
Rebamipide suppresses collagen-induced arthritis through reciprocal regulation of th17/treg cell differentiation and heme oxygenase 1 inductionSu-Jin Moon, Jin-Sil Park, Yun-Ju Woo, et al.Cancer Research and Treatment|March 6, 2025
Ten-Year Follow-Up Clinical Outcomes and the Role of Adjuvant Chemotherapy in HER2-Positive Patients with Microinvasive Breast CancerYeokyeong Shin, Soo-Young Lee, Hyehyun Jeong, et al.Clinical Immunology (Orlando, Fla.)|June 22, 2024
Expansion of tumor-infiltrating lymphocytes in non-small cell lung cancer: Clinical potential and efficacy in EGFR mutation subsetsHyun Lee, Miseon Lee, Chae Lyul Lim, et al.American Journal of Cancer Research|October 12, 2020
Blockade of CCL2 expression overcomes intrinsic PD-1/PD-L1 inhibitor-resistance in transglutaminase 2-induced PD-L1 positive triple negative breast cancerJunyoung Choi, Hee Jin Lee, Shinkyo Yoon, et al.Pageof 24